{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:55:22Z","timestamp":1790625322143,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5R01DA048860-05"],"award-info":[{"award-number":["5R01DA048860-05"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["5K01AT012205-03"],"award-info":[{"award-number":["5K01AT012205-03"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"DOI":"10.1007\/s11606-026-10733-8","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:59:30Z","timestamp":1790621970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cannabis Legalization and Opioid Prescribing in Veterans Health Administration Patients: 2013\u20132022"],"prefix":"10.1007","author":[{"given":"Zachary L.","family":"Mannes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie M.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malki","family":"Stohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Malte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Olfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofir","family":"Livne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline G.","family":"Wisell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomeh","family":"Keyhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia S.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Cerd\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana L.","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gutkind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Maynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6533-7021","authenticated-orcid":false,"given":"Deborah S.","family":"Hasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"10733_CR1","doi-asserted-by":"publisher","unstructured":"Rikard SM, Strahan AE, Schmit KM, Guy GP. Chronic Pain Among Adults \u2014 United States, 2019\u20132021. MMWR Morb Mortal Wkly Rep. 2023;72(15). https:\/\/doi.org\/10.15585\/mmwr.mm7215a1.","DOI":"10.15585\/mmwr.mm7215a1"},{"key":"10733_CR2","doi-asserted-by":"publisher","unstructured":"Goldstick JE, Guy GP, Losby JL, Baldwin G, Myers M, Bohnert ASB. Changes in Initial Opioid Prescribing Practices after the 2016 Release of the CDC Guideline for Prescribing Opioids for Chronic Pain. JAMA Netw Open. 2021;4(7). https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.16860.","DOI":"10.1001\/jamanetworkopen.2021.16860"},{"issue":"17","key":"10733_CR3","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1001\/jama.2026.3241","volume":"335","author":"TD Nguyen","year":"2026","unstructured":"Nguyen TD, Chua KP, Jiao A, Bicket MC, Bohnert A, Lagisetty P. US Trends in Long-Term Opioid Therapy. JAMA. 2026;335(17):1529-1531. https:\/\/doi.org\/10.1001\/jama.2026.3241.","journal-title":"JAMA."},{"key":"10733_CR4","doi-asserted-by":"publisher","unstructured":"Agarwal SD, Landon BE. Patterns in Outpatient Benzodiazepine Prescribing in the United States. JAMA Netw Open. 2019;2(1). https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.7399.","DOI":"10.1001\/jamanetworkopen.2018.7399"},{"key":"10733_CR5","doi-asserted-by":"publisher","unstructured":"Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, MacKey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: Retrospective analysis. BMJ (Online). 2017;356. https:\/\/doi.org\/10.1136\/bmj.j760.","DOI":"10.1136\/bmj.j760"},{"key":"10733_CR6","doi-asserted-by":"publisher","unstructured":"Xu KY, Hartz SM, Borodovsky JT, Bierut LJ, Grucza RA. Association between Benzodiazepine Use with or without Opioid Use and All-Cause Mortality in the United States, 1999\u20132015. JAMA Netw Open. 2020;3(12). https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.28557.","DOI":"10.1001\/jamanetworkopen.2020.28557"},{"key":"10733_CR7","doi-asserted-by":"publisher","unstructured":"Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a national institutes of health pathways to prevention workshop. Ann Intern Med. 2015;162(4). https:\/\/doi.org\/10.7326\/M14-2559.","DOI":"10.7326\/M14-2559"},{"key":"10733_CR8","doi-asserted-by":"publisher","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep. 2022;71(3). https:\/\/doi.org\/10.15585\/mmwr.rr7103a1.","DOI":"10.15585\/mmwr.rr7103a1"},{"key":"10733_CR9","doi-asserted-by":"publisher","unstructured":"Taha SA, Westra JR, Tacker DH, Raji MA, Kuo YF. Trends in co-prescribed opioids and benzodiazepines, non-prescribed opioids and benzodiazepines, and schedule-I drugs in the United States, 2013 to 2019. Prev Med Rep. 2024;38. https:\/\/doi.org\/10.1016\/j.pmedr.2023.102584.","DOI":"10.1016\/j.pmedr.2023.102584"},{"key":"10733_CR10","doi-asserted-by":"publisher","unstructured":"Guy GP, Khushalani JS, Jackson H, Sims RSC, Arifkhanova A. Trends in State-Level Pharmacy-Based Naloxone Dispensing Rates, 2012\u20132019. Am J Prev Med. 2021;61(6). https:\/\/doi.org\/10.1016\/j.amepre.2021.05.042.","DOI":"10.1016\/j.amepre.2021.05.042"},{"key":"10733_CR11","doi-asserted-by":"publisher","unstructured":"Olfson M, Wang S, Wall MM, Blanco C. Trends in opioid prescribing and self-reported pain among us adults. Health Aff. 2020;39(1). https:\/\/doi.org\/10.1377\/hlthaff.2019.00783.","DOI":"10.1377\/hlthaff.2019.00783"},{"key":"10733_CR12","unstructured":"Centers for Disease Control and Prevention. United States Dispensing Rate Maps. https:\/\/www.cdc.gov\/overdose-prevention\/data-research\/facts-stats\/us-dispensing-rate-maps.html. November 7, 2024."},{"key":"10733_CR13","doi-asserted-by":"publisher","unstructured":"Dai H, Richter KP. A National Survey of Marijuana Use Among US Adults With Medical Conditions, 2016\u20132017. JAMA Netw Open. 2019;2(9). https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.11936.","DOI":"10.1001\/jamanetworkopen.2019.11936"},{"key":"10733_CR14","doi-asserted-by":"publisher","unstructured":"Jeddi HM, Busse JW, Sadeghirad B, et al. Cannabis for medical use versus opioids for chronic non-cancer pain: A systematic review and network meta-analysis of randomised clinical trials. BMJ Open. 2024;14(1). https:\/\/doi.org\/10.1136\/bmjopen-2022-068182.","DOI":"10.1136\/bmjopen-2022-068182"},{"key":"10733_CR15","unstructured":"Espinoza-Kulick MAV, Espinoza-Kulick A. Marijuana Policy Project (MPP). In: Marijuana in America: Cultural, Political, and Medical Controversies. 2022."},{"key":"10733_CR16","doi-asserted-by":"publisher","unstructured":"Boehnke KF, Gangopadhyay S, Clauw DJ, Haffajee RL. Qualifying conditions of medical cannabis license holders in the United States. Health Aff. 2019;38(2). https:\/\/doi.org\/10.1377\/hlthaff.2018.05266.","DOI":"10.1377\/hlthaff.2018.05266"},{"key":"10733_CR17","doi-asserted-by":"publisher","unstructured":"Yanes JA, McKinnell ZE, Reid MA, et al. Effects of cannabinoid administration for pain: A meta-analysis and meta-regression. Exp Clin Psychopharmacol. 2019;27(4). https:\/\/doi.org\/10.1037\/pha0000281.","DOI":"10.1037\/pha0000281"},{"key":"10733_CR18","doi-asserted-by":"publisher","unstructured":"Wang L, Hong PJ, May C, et al. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: A systematic review and meta-analysis of randomised clinical trials. The BMJ. 2021;374. https:\/\/doi.org\/10.1136\/bmj.n1034.","DOI":"10.1136\/bmj.n1034"},{"key":"10733_CR19","doi-asserted-by":"publisher","unstructured":"De Vita MJ, Moskal D, Maisto SA, Ansell EB. Association of Cannabinoid Administration with Experimental Pain in Healthy Adults: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2018;75(11). https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.2503.","DOI":"10.1001\/jamapsychiatry.2018.2503"},{"key":"10733_CR20","doi-asserted-by":"publisher","unstructured":"Nugent SM, Morasco BJ, O\u2019Neil ME, et al. The effects of cannabis among adults with chronic painandan overview of general harms a systematic review. Ann Intern Med. 2017;167(5). https:\/\/doi.org\/10.7326\/M17-0155.","DOI":"10.7326\/M17-0155"},{"key":"10733_CR21","doi-asserted-by":"publisher","unstructured":"Stockings E, Campbell G, Hall WD, et al. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: A systematic review and meta-analysis of controlled and observational studies. Pain. 2018;159(10). https:\/\/doi.org\/10.1097\/j.pain.0000000000001293.","DOI":"10.1097\/j.pain.0000000000001293"},{"key":"10733_CR22","doi-asserted-by":"publisher","unstructured":"Kansagara D, Hill KP, Yost J, et al. Cannabis or Cannabinoids for the Management of Chronic Noncancer Pain: Best Practice Advice From the American College of Physicians. Ann Intern Med. 2025;178(5). https:\/\/doi.org\/10.7326\/ANNALS-24-03319","DOI":"10.7326\/ANNALS-24-03319"},{"key":"10733_CR23","doi-asserted-by":"publisher","unstructured":"Keyhani S, Steigerwald S, Ishida J, et al. Risks and benefits of marijuana use a national survey of U.S. Adults. Ann Intern Med. 2018;169(5). https:\/\/doi.org\/10.7326\/M18-0810.","DOI":"10.7326\/M18-0810"},{"key":"10733_CR24","doi-asserted-by":"publisher","unstructured":"Bicket MC, Stone EM, Mcginty EE. Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs. JAMA Netw Open. 2023;6(1). https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.49797.","DOI":"10.1001\/jamanetworkopen.2022.49797"},{"key":"10733_CR25","doi-asserted-by":"publisher","unstructured":"McMichael BJ, Van Horn RL, Viscusi WK. The impact of cannabis access laws on opioid prescribing. J Health Econ. 2020;69. https:\/\/doi.org\/10.1016\/j.jhealeco.2019.102273.","DOI":"10.1016\/j.jhealeco.2019.102273"},{"key":"10733_CR26","doi-asserted-by":"publisher","unstructured":"Bradford AC, Bradford WD, Abraham A, Adams GB. Association between US state medical cannabis laws and opioid prescribing in the medicare part D population. JAMA Intern Med. 2018;178(5). https:\/\/doi.org\/10.1001\/jamainternmed.2018.0266.","DOI":"10.1001\/jamainternmed.2018.0266"},{"key":"10733_CR27","doi-asserted-by":"publisher","unstructured":"Wen H, Hockenberry JM. Association of medical and adult-use marijuana laws with opioid prescribing for medicaid enrollees. JAMA Intern Med. 2018;178(5). https:\/\/doi.org\/10.1001\/jamainternmed.2018.1007.","DOI":"10.1001\/jamainternmed.2018.1007"},{"key":"10733_CR28","doi-asserted-by":"publisher","unstructured":"Slawek DE, Zhang C, Dahmer S, et al. Medical Cannabis and Opioid Receipt Among Adults With Chronic Pain. JAMA Intern Med. Published online 2025. https:\/\/doi.org\/10.1001\/jamainternmed.2025.6496.","DOI":"10.1001\/jamainternmed.2025.6496"},{"key":"10733_CR29","doi-asserted-by":"publisher","unstructured":"Nguyen T, Li Y, Greene D, Stancliff S, Quackenbush N. Changes in Prescribed Opioid Dosages Among Patients Receiving Medical Cannabis for Chronic Pain, New York State, 2017\u20132019. JAMA Netw Open. 2023;6(1). https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.54573.","DOI":"10.1001\/jamanetworkopen.2022.54573"},{"key":"10733_CR30","doi-asserted-by":"publisher","unstructured":"McGinty EE, Tormohlen KN, Seewald NJ, et al. Effects of U.S. State Medical Cannabis Laws on Treatment of Chronic Noncancer Pain. Ann Intern Med. 2023;176(7). https:\/\/doi.org\/10.7326\/M23-0053.","DOI":"10.7326\/M23-0053"},{"key":"10733_CR31","doi-asserted-by":"publisher","unstructured":"Shah A, Hayes CJ, Lakkad M, Martin BC. Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use. J Gen Intern Med. 2019;34(8). https:\/\/doi.org\/10.1007\/s11606-018-4782-2.","DOI":"10.1007\/s11606-018-4782-2"},{"key":"10733_CR32","doi-asserted-by":"publisher","unstructured":"Mannes ZL, Malte CA, Olfson M, et al. Increasing risk of cannabis use disorder among U.S. veterans with chronic pain: 2005\u20132019. Pain. 2023;164(9). https:\/\/doi.org\/10.1097\/j.pain.0000000000002920.","DOI":"10.1097\/j.pain.0000000000002920"},{"key":"10733_CR33","unstructured":"U.S. Department of Veterans Affairs. VA reduces number of Veterans prescribed opioids by 67% since 2012. https:\/\/news.va.gov\/press-room\/va-reduces-prescription-opioid-use-by-64-during-past-eight-years\/. September 21, 2023."},{"key":"10733_CR34","doi-asserted-by":"publisher","unstructured":"Veteran Access to Multiple Forms of Health Care Coverage: Veterans\u2019 Issues in Focus. 2025. https:\/\/doi.org\/10.7249\/pea1363-15.","DOI":"10.7249\/pea1363-15"},{"key":"10733_CR35","doi-asserted-by":"publisher","unstructured":"Han BH, Yang KH, Cleland CM, Palamar JJ. Trends in Past-Month Cannabis Use Among Older Adults. JAMA Intern Med. 2025;185(7). https:\/\/doi.org\/10.1001\/jamainternmed.2025.1156.","DOI":"10.1001\/jamainternmed.2025.1156"},{"key":"10733_CR36","doi-asserted-by":"publisher","unstructured":"Dahlhamer JM, Connor EM, Bose J, Lucas JW, Zelaya CE. Prescription opioid use among adults with chronic pain: United states, 2019. Natl Health Stat Report. 2021;2021(162). https:\/\/doi.org\/10.15620\/cdc:107641.","DOI":"10.15620\/cdc"},{"key":"10733_CR37","doi-asserted-by":"publisher","unstructured":"Dufort A, Samaan Z. Problematic Opioid Use Among Older Adults: Epidemiology, Adverse Outcomes and Treatment Considerations. Drugs Aging. 2021;38(12). https:\/\/doi.org\/10.1007\/s40266-021-00893-z.","DOI":"10.1007\/s40266-021-00893-z"},{"key":"10733_CR38","doi-asserted-by":"publisher","unstructured":"Mayhew M, DeBar LL, Deyo RA, et al. Development and Assessment of a Crosswalk Between ICD-9-CM and ICD-10-CM to Identify Patients with Common Pain Conditions. Journal of Pain. 2019;20(12). https:\/\/doi.org\/10.1016\/j.jpain.2019.05.006.","DOI":"10.1016\/j.jpain.2019.05.006"},{"key":"10733_CR39","doi-asserted-by":"publisher","unstructured":"Hasin DS, Wall MM, Alschuler DM, et al. Chronic pain, cannabis legalisation, and cannabis use disorder among patients in the US Veterans Health Administration system, 2005 to 2019: a repeated, cross-sectional study. Lancet Psychiatry. 2023;10(11). https:\/\/doi.org\/10.1016\/S2215-0366(23)00268-7.","DOI":"10.1016\/S2215-0366(23)00268-7"},{"key":"10733_CR40","doi-asserted-by":"publisher","unstructured":"Sandbrink F, Murphy JL, Johansson M, et al. The Use of Opioids in the Management of Chronic Pain: Synopsis of the 2022 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Ann Intern Med. 2023;176(3). https:\/\/doi.org\/10.7326\/M22-2917.","DOI":"10.7326\/M22-2917"},{"key":"10733_CR41","doi-asserted-by":"publisher","unstructured":"Karmali RN, Bush C, Raman SR, Campbell CI, Skinner AC, Roberts AW. Long-term opioid therapy definitions and predictors: A systematic review. Pharmacoepidemiol Drug Saf. 2020;29(3). https:\/\/doi.org\/10.1002\/pds.4929.","DOI":"10.1002\/pds.4929"},{"key":"10733_CR42","doi-asserted-by":"publisher","unstructured":"Sullivan MD, Ballantyne JC. Understanding the Risks of Long-Term Opioid Therapy for Chronic Pain. American Journal of Psychiatry. 2022;179(10). https:\/\/doi.org\/10.1176\/appi.ajp.20220592.","DOI":"10.1176\/appi.ajp.20220592"},{"key":"10733_CR43","doi-asserted-by":"publisher","unstructured":"Liang D, Guo H, Shi Y. Mandatory use of prescription drug monitoring program and benzodiazepine prescribing among U.S. Medicaid enrollees. Subst Abus. 2021;42(3). https:\/\/doi.org\/10.1080\/08897077.2019.1686722.","DOI":"10.1080\/08897077.2019.1686722"},{"key":"10733_CR44","doi-asserted-by":"publisher","unstructured":"Puac-Polanco V, Chihuri S, Fink DS, Cerd\u00e1 M, Keyes KM, Li G. Prescription Drug Monitoring Programs and Prescription Opioid-Related Outcomes in the United States. Epidemiol Rev. 2020;42(1). https:\/\/doi.org\/10.1093\/epirev\/mxaa002.","DOI":"10.1093\/epirev\/mxaa002"},{"key":"10733_CR45","unstructured":"Center for Behavioral Health Statistics S. Key Substance Use and Mental Health Indicators in the United States: Results from the 2024 National Survey on Drug Use and Health. https:\/\/library.samhsa.gov\/."},{"issue":"12","key":"10733_CR46","doi-asserted-by":"publisher","first-page":"e2451821","DOI":"10.1001\/jamanetworkopen.2024.51821","volume":"7","author":"LR Gorfinkel","year":"2024","unstructured":"Gorfinkel LR, Malte CA, Fink DS, et al. Trends in Opioid Use Disorder in the Veterans Health Administration, 2005-2022. JAMA Netw Open. 2024;7(12):e2451821. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.51821.","journal-title":"JAMA Netw Open."},{"key":"10733_CR47","unstructured":"Spencer MR, Garnett MF, Mini\u00f1o AM. Drug Overdose Deaths in the United States, 2002\u20132022 Key Findings Data from the National Vital Statistics System. 2002. https:\/\/www.cdc.gov\/nchs\/products\/index.htm."},{"key":"10733_CR48","doi-asserted-by":"publisher","unstructured":"Lin LA, Bohnert ASB, Kerns RD, Clay MA, Ganoczy D, Ilgen MA. Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans. Pain. 2017;158(5). https:\/\/doi.org\/10.1097\/j.pain.0000000000000837.","DOI":"10.1097\/j.pain.0000000000000837"},{"key":"10733_CR49","doi-asserted-by":"publisher","unstructured":"Townsend T, Cerd\u00e1 M, Bohnert A, Lagisetty P, Haffajee RL. CDC Guideline For Opioid Prescribing Associated With Reduced Dispensing To Certain Patients With Chronic Pain. Health Aff. 2021;40(11). https:\/\/doi.org\/10.1377\/hlthaff.2021.00135.","DOI":"10.1377\/hlthaff.2021.00135"},{"key":"10733_CR50","doi-asserted-by":"publisher","unstructured":"Rosenberg JM, Bilka BM, Wilson SM, Spevak C. Opioid therapy for chronic pain: Overview of the 2017 us department of veterans affairs and us department of defense clinical practice guideline. Pain Medicine (United States). 2018;19(5). https:\/\/doi.org\/10.1093\/pm\/pnx203.","DOI":"10.1093\/pm\/pnx203"},{"key":"10733_CR51","doi-asserted-by":"publisher","unstructured":"Zeliadt SB, Douglas JH, Gelman H, et al. Effectiveness of a whole health model of care emphasizing complementary and integrative health on reducing opioid use among patients with chronic pain. BMC Health Serv Res. 2022;22(1). https:\/\/doi.org\/10.1186\/s12913-022-08388-2","DOI":"10.1186\/s12913-022-08388-2"},{"key":"10733_CR52","doi-asserted-by":"publisher","unstructured":"Han BH, Palamar JJ. Trends in Cannabis Use among Older Adults in the United States, 2015\u20132018. JAMA Intern Med. 2020;180(4). https:\/\/doi.org\/10.1001\/jamainternmed.2019.7517.","DOI":"10.1001\/jamainternmed.2019.7517"},{"key":"10733_CR53","doi-asserted-by":"publisher","unstructured":"Bonn-Miller MO, Vujanovic AA, Drescher KD. Cannabis use among military veterans after residential treatment for posttraumatic stress disorder. Psychology of Addictive Behaviors. 2011;25(3). https:\/\/doi.org\/10.1037\/a0021945.","DOI":"10.1037\/a0021945"},{"key":"10733_CR54","doi-asserted-by":"publisher","unstructured":"Lee B, Zhao W, Yang KC, Ahn YY, Perry BL. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007\u20132018. JAMA Netw Open. 2021;4(2). https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.36687.","DOI":"10.1001\/jamanetworkopen.2020.36687"},{"key":"10733_CR55","doi-asserted-by":"publisher","unstructured":"Kansagara D, Morasco BJ, Iacocca MO, Bair MJ, Hooker ER, Becker WC. Clinician knowledge, attitudes, and practice regarding cannabis: Results from a national veterans health administration survey. Pain Medicine (United States). 2020;21(11). https:\/\/doi.org\/10.1093\/PM\/PNZ322.","DOI":"10.1093\/PM\/PNZ322"},{"key":"10733_CR56","doi-asserted-by":"publisher","unstructured":"Krebs EE, Clothier B, Nugent S, et al. The evaluating prescription opioid changes in veterans (EPOCH) study: Design, survey response, and baseline characteristics. PLoS One. 2020;15(4). https:\/\/doi.org\/10.1371\/journal.pone.0230751.","DOI":"10.1371\/journal.pone.0230751"},{"key":"10733_CR57","doi-asserted-by":"publisher","unstructured":"Gutkind S, Fink DS, Shmulewitz D, Stohl M, Hasin D. Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in U.S. adults. Drug Alcohol Depend. 2021;229. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109137.","DOI":"10.1016\/j.drugalcdep.2021.109137"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10733-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-026-10733-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10733-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:59:33Z","timestamp":1790621973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-026-10733-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":57,"alternative-id":["10733"],"URL":"https:\/\/doi.org\/10.1007\/s11606-026-10733-8","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Human Ethics and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MC provides expert testimony for opioid litigation. AJS provides expert testimony for various law firms in the United States. AJS receives royalties from UptoDate Inc. and receives consulting fees for Lundbeck and Boehringer Ingelheim pharmaceuticals. DSH reported nonfinancial support from the New York State Psychiatric Institute and VA Centers of Excellence in Substance Addiction Treatment and Education during the conduct of the study as well as research support from Syneos Health.","order":2,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}